Herceptin Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type
By: HDIN Research
Published: 2025-05-25
Pages: 87
Market Research Report Price
- Single User License (1 Users) $ 3,200
- Team License (2~5 Users) $ 4,200
- Corporate License (>5 Users) $ 5,200
Herceptin Market Summary
Introduction and Market Overview
Herceptin (trastuzumab) is a monoclonal antibody targeting HER2-positive cancers, primarily breast cancer and stomach/gastric cancer, with HER2-positive breast cancer accounting for 15-20% of 2.5 million new breast cancer cases globally in 2020. The market is driven by the high incidence of breast cancer, advancements in precision medicine, where targeted therapies constitute 40% of cancer treatments, and the increasing adoption of biosimilars, which have boosted usage by 30% in low-income countries. The aging population, improved diagnostics, and expanded access to oncology care further fuel demand. The global Herceptin market is estimated at USD 1.5-3.0 billion in 2025, with a compound annual growth rate (CAGR) of 3%-7% through 2030.
Regional Market Trends
North America: The U.S. leads with widespread HER2 testing and biosimilar adoption, while Canada focuses on oncology access in rural areas.
Europe: Germany, France, and the UK drive growth with robust reimbursement for biologics and biosimilars.
Asia Pacific: China and India see rising demand due to increasing breast cancer incidence, with Japan emphasizing precision oncology.
Rest of the World: Brazil expands public health access to biosimilars, while the Middle East invests in cancer care infrastructure.
Application Analysis
Breast Cancer: Expected growth of 3.2%-7.2%, driven by high HER2-positive prevalence. Trends focus on combination therapies with chemotherapy.
Stomach/Gastric Cancer: Projected growth of 2.8%-6.8%, linked to niche indications. Advances emphasize adjuvant use in advanced cases.
Type Analysis
Biologic: Expected growth of 2.5%-6.5%, valued for established efficacy. Trends highlight combination regimens.
Biosimilar: Projected growth of 3.5%-7.5%, favored for cost-effectiveness. Advances focus on expanding access in emerging markets.
Key Market Players
Roche: Pioneers Herceptin for HER2-positive cancers.
Amgen: Develops trastuzumab biosimilars for oncology.
Pfizer: Offers biosimilars to enhance affordability.
Samsung Bioepis: Focuses on cost-effective biosimilars.
Celltrion: Provides trastuzumab biosimilars for global markets.
Porter’s Five Forces Analysis
Threat of New Entrants: Moderate, due to high R&D costs and regulatory barriers, but biosimilars lower entry hurdles.
Threat of Substitutes: Moderate, with newer targeted therapies competing, though Herceptin remains a standard for HER2-positive cancers.
Bargaining Power of Buyers: High, as biosimilars increase price competition, giving hospitals leverage.
Bargaining Power of Suppliers: Low, with multiple providers of biologics manufacturing.
Competitive Rivalry: High, with biosimilar manufacturers competing on price and market access.
Market Opportunities and Challenges
Opportunities:
Addressing HER2-positive breast cancer, with 15-20% of 2.5 million cases.
Leveraging precision medicine, constituting 40% of cancer treatments.
Utilizing biosimilars, with 30% increased usage in low-income countries.
Supporting early diagnosis through HER2 testing programs.
Meeting demand from aging populations with higher cancer risk.
Expanding access in emerging markets via biosimilars.
Challenges:
High costs of biologics limiting access in low-income regions.
Competition from newer targeted therapies.
Regulatory delays for biosimilar approvals.
Price erosion due to widespread biosimilars.
Limited oncology infrastructure in developing regions.
Introduction and Market Overview
Herceptin (trastuzumab) is a monoclonal antibody targeting HER2-positive cancers, primarily breast cancer and stomach/gastric cancer, with HER2-positive breast cancer accounting for 15-20% of 2.5 million new breast cancer cases globally in 2020. The market is driven by the high incidence of breast cancer, advancements in precision medicine, where targeted therapies constitute 40% of cancer treatments, and the increasing adoption of biosimilars, which have boosted usage by 30% in low-income countries. The aging population, improved diagnostics, and expanded access to oncology care further fuel demand. The global Herceptin market is estimated at USD 1.5-3.0 billion in 2025, with a compound annual growth rate (CAGR) of 3%-7% through 2030.
Regional Market Trends
North America: The U.S. leads with widespread HER2 testing and biosimilar adoption, while Canada focuses on oncology access in rural areas.
Europe: Germany, France, and the UK drive growth with robust reimbursement for biologics and biosimilars.
Asia Pacific: China and India see rising demand due to increasing breast cancer incidence, with Japan emphasizing precision oncology.
Rest of the World: Brazil expands public health access to biosimilars, while the Middle East invests in cancer care infrastructure.
Application Analysis
Breast Cancer: Expected growth of 3.2%-7.2%, driven by high HER2-positive prevalence. Trends focus on combination therapies with chemotherapy.
Stomach/Gastric Cancer: Projected growth of 2.8%-6.8%, linked to niche indications. Advances emphasize adjuvant use in advanced cases.
Type Analysis
Biologic: Expected growth of 2.5%-6.5%, valued for established efficacy. Trends highlight combination regimens.
Biosimilar: Projected growth of 3.5%-7.5%, favored for cost-effectiveness. Advances focus on expanding access in emerging markets.
Key Market Players
Roche: Pioneers Herceptin for HER2-positive cancers.
Amgen: Develops trastuzumab biosimilars for oncology.
Pfizer: Offers biosimilars to enhance affordability.
Samsung Bioepis: Focuses on cost-effective biosimilars.
Celltrion: Provides trastuzumab biosimilars for global markets.
Porter’s Five Forces Analysis
Threat of New Entrants: Moderate, due to high R&D costs and regulatory barriers, but biosimilars lower entry hurdles.
Threat of Substitutes: Moderate, with newer targeted therapies competing, though Herceptin remains a standard for HER2-positive cancers.
Bargaining Power of Buyers: High, as biosimilars increase price competition, giving hospitals leverage.
Bargaining Power of Suppliers: Low, with multiple providers of biologics manufacturing.
Competitive Rivalry: High, with biosimilar manufacturers competing on price and market access.
Market Opportunities and Challenges
Opportunities:
Addressing HER2-positive breast cancer, with 15-20% of 2.5 million cases.
Leveraging precision medicine, constituting 40% of cancer treatments.
Utilizing biosimilars, with 30% increased usage in low-income countries.
Supporting early diagnosis through HER2 testing programs.
Meeting demand from aging populations with higher cancer risk.
Expanding access in emerging markets via biosimilars.
Challenges:
High costs of biologics limiting access in low-income regions.
Competition from newer targeted therapies.
Regulatory delays for biosimilar approvals.
Price erosion due to widespread biosimilars.
Limited oncology infrastructure in developing regions.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Herceptin Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Herceptin Market in North America (2020-2030)
8.1 Herceptin Market Size
8.2 Herceptin Market by End Use
8.3 Competition by Players/Suppliers
8.4 Herceptin Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Herceptin Market in South America (2020-2030)
9.1 Herceptin Market Size
9.2 Herceptin Market by End Use
9.3 Competition by Players/Suppliers
9.4 Herceptin Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Herceptin Market in Asia & Pacific (2020-2030)
10.1 Herceptin Market Size
10.2 Herceptin Market by End Use
10.3 Competition by Players/Suppliers
10.4 Herceptin Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Herceptin Market in Europe (2020-2030)
11.1 Herceptin Market Size
11.2 Herceptin Market by End Use
11.3 Competition by Players/Suppliers
11.4 Herceptin Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Herceptin Market in MEA (2020-2030)
12.1 Herceptin Market Size
12.2 Herceptin Market by End Use
12.3 Competition by Players/Suppliers
12.4 Herceptin Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Herceptin Market (2020-2025)
13.1 Herceptin Market Size
13.2 Herceptin Market by End Use
13.3 Competition by Players/Suppliers
13.4 Herceptin Market Size by Type
Chapter 14 Global Herceptin Market Forecast (2025-2030)
14.1 Herceptin Market Size Forecast
14.2 Herceptin Application Forecast
14.3 Competition by Players/Suppliers
14.4 Herceptin Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Herceptin Information
15.1.3 SWOT Analysis of Roche
15.1.4 Roche Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.2 Amgen
15.2.1 Company Profile
15.2.2 Main Business and Herceptin Information
15.2.3 SWOT Analysis of Amgen
15.2.4 Amgen Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.3 Pfizer
15.3.1 Company Profile
15.3.2 Main Business and Herceptin Information
15.3.3 SWOT Analysis of Pfizer
15.3.4 Pfizer Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.4 Samsung Bioepis
15.4.1 Company Profile
15.4.2 Main Business and Herceptin Information
15.4.3 SWOT Analysis of Samsung Bioepis
15.4.4 Samsung Bioepis Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.5 Viatris
15.5.1 Company Profile
15.5.2 Main Business and Herceptin Information
15.5.3 SWOT Analysis of Viatris
15.5.4 Viatris Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.6 Celltrion
15.6.1 Company Profile
15.6.2 Main Business and Herceptin Information
15.6.3 SWOT Analysis of Celltrion
15.6.4 Celltrion Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
Please ask for sample pages for full companies list
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Herceptin Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Herceptin Market in North America (2020-2030)
8.1 Herceptin Market Size
8.2 Herceptin Market by End Use
8.3 Competition by Players/Suppliers
8.4 Herceptin Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Herceptin Market in South America (2020-2030)
9.1 Herceptin Market Size
9.2 Herceptin Market by End Use
9.3 Competition by Players/Suppliers
9.4 Herceptin Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Herceptin Market in Asia & Pacific (2020-2030)
10.1 Herceptin Market Size
10.2 Herceptin Market by End Use
10.3 Competition by Players/Suppliers
10.4 Herceptin Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Herceptin Market in Europe (2020-2030)
11.1 Herceptin Market Size
11.2 Herceptin Market by End Use
11.3 Competition by Players/Suppliers
11.4 Herceptin Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Herceptin Market in MEA (2020-2030)
12.1 Herceptin Market Size
12.2 Herceptin Market by End Use
12.3 Competition by Players/Suppliers
12.4 Herceptin Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Herceptin Market (2020-2025)
13.1 Herceptin Market Size
13.2 Herceptin Market by End Use
13.3 Competition by Players/Suppliers
13.4 Herceptin Market Size by Type
Chapter 14 Global Herceptin Market Forecast (2025-2030)
14.1 Herceptin Market Size Forecast
14.2 Herceptin Application Forecast
14.3 Competition by Players/Suppliers
14.4 Herceptin Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Herceptin Information
15.1.3 SWOT Analysis of Roche
15.1.4 Roche Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.2 Amgen
15.2.1 Company Profile
15.2.2 Main Business and Herceptin Information
15.2.3 SWOT Analysis of Amgen
15.2.4 Amgen Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.3 Pfizer
15.3.1 Company Profile
15.3.2 Main Business and Herceptin Information
15.3.3 SWOT Analysis of Pfizer
15.3.4 Pfizer Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.4 Samsung Bioepis
15.4.1 Company Profile
15.4.2 Main Business and Herceptin Information
15.4.3 SWOT Analysis of Samsung Bioepis
15.4.4 Samsung Bioepis Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.5 Viatris
15.5.1 Company Profile
15.5.2 Main Business and Herceptin Information
15.5.3 SWOT Analysis of Viatris
15.5.4 Viatris Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
15.6 Celltrion
15.6.1 Company Profile
15.6.2 Main Business and Herceptin Information
15.6.3 SWOT Analysis of Celltrion
15.6.4 Celltrion Herceptin Sales, Revenue, Price and Gross Margin (2020-2025)
Please ask for sample pages for full companies list
Table Abbreviation And Acronyms
Table Research Scope Of Herceptin Report
Table Data Sources Of Herceptin Report
Table Major Assumptions Of Herceptin Report
Table Herceptin Classification
Table Herceptin Applications
Table Drivers Of Herceptin Market
Table Restraints Of Herceptin Market
Table Opportunities Of Herceptin Market
Table Threats Of Herceptin Market
Table Raw Materials Suppliers
Table Different Production Methods Of Herceptin
Table Cost Structure Analysis Of Herceptin
Table Key End Users
Table Latest News Of Herceptin Market
Table Merger And Acquisition
Table Planned/Future Project Of Herceptin Market
Table Policy Of Herceptin Market
Table 2020-2030 North America Herceptin Market Size
Table 2020-2030 North America Herceptin Market Size By Application
Table 2020-2025 North America Herceptin Key Players Revenue
Table 2020-2025 North America Herceptin Key Players Market Share
Table 2020-2030 North America Herceptin Market Size By Type
Table 2020-2030 United States Herceptin Market Size
Table 2020-2030 Canada Herceptin Market Size
Table 2020-2030 Mexico Herceptin Market Size
Table 2020-2030 South America Herceptin Market Size
Table 2020-2030 South America Herceptin Market Size By Application
Table 2020-2025 South America Herceptin Key Players Revenue
Table 2020-2025 South America Herceptin Key Players Market Share
Table 2020-2030 South America Herceptin Market Size By Type
Table 2020-2030 Brazil Herceptin Market Size
Table 2020-2030 Argentina Herceptin Market Size
Table 2020-2030 Chile Herceptin Market Size
Table 2020-2030 Peru Herceptin Market Size
Table 2020-2030 Asia & Pacific Herceptin Market Size
Table 2020-2030 Asia & Pacific Herceptin Market Size By Application
Table 2020-2025 Asia & Pacific Herceptin Key Players Revenue
Table 2020-2025 Asia & Pacific Herceptin Key Players Market Share
Table 2020-2030 Asia & Pacific Herceptin Market Size By Type
Table 2020-2030 China Herceptin Market Size
Table 2020-2030 India Herceptin Market Size
Table 2020-2030 Japan Herceptin Market Size
Table 2020-2030 South Korea Herceptin Market Size
Table 2020-2030 Southeast Asia Herceptin Market Size
Table 2020-2030 Australia Herceptin Market Size
Table 2020-2030 Europe Herceptin Market Size
Table 2020-2030 Europe Herceptin Market Size By Application
Table 2020-2025 Europe Herceptin Key Players Revenue
Table 2020-2025 Europe Herceptin Key Players Market Share
Table 2020-2030 Europe Herceptin Market Size By Type
Table 2020-2030 Germany Herceptin Market Size
Table 2020-2030 France Herceptin Market Size
Table 2020-2030 United Kingdom Herceptin Market Size
Table 2020-2030 Italy Herceptin Market Size
Table 2020-2030 Spain Herceptin Market Size
Table 2020-2030 Belgium Herceptin Market Size
Table 2020-2030 Netherlands Herceptin Market Size
Table 2020-2030 Austria Herceptin Market Size
Table 2020-2030 Poland Herceptin Market Size
Table 2020-2030 Russia Herceptin Market Size
Table 2020-2030 Mea Herceptin Market Size
Table 2020-2030 Mea Herceptin Market Size By Application
Table 2020-2025 Mea Herceptin Key Players Revenue
Table 2020-2025 Mea Herceptin Key Players Market Share
Table 2020-2030 Mea Herceptin Market Size By Type
Table 2020-2030 Egypt Herceptin Market Size
Table 2020-2030 Israel Herceptin Market Size
Table 2020-2030 South Africa Herceptin Market Size
Table 2020-2030 Gulf Cooperation Council Countries Herceptin Market Size
Table 2020-2030 Turkey Herceptin Market Size
Table 2020-2025 Global Herceptin Market Size By Region
Table 2020-2025 Global Herceptin Market Size Share By Region
Table 2020-2025 Global Herceptin Market Size By Application
Table 2020-2025 Global Herceptin Market Share By Application
Table 2020-2025 Global Herceptin Key Vendors Revenue
Table 2020-2025 Global Herceptin Key Vendors Market Share
Table 2020-2025 Global Herceptin Market Size By Type
Table 2020-2025 Global Herceptin Market Share By Type
Table 2025-2030 Global Herceptin Market Size By Region
Table 2025-2030 Global Herceptin Market Size Share By Region
Table 2025-2030 Global Herceptin Market Size By Application
Table 2025-2030 Global Herceptin Market Share By Application
Table 2025-2030 Global Herceptin Key Vendors Revenue
Table 2025-2030 Global Herceptin Key Vendors Market Share
Table 2025-2030 Global Herceptin Market Size By Type
Table 2025-2030 Herceptin Global Market Share By Type
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Herceptin Picture
Figure 2020-2030 North America Herceptin Market Size And Cagr
Figure 2020-2030 South America Herceptin Market Size And Cagr
Figure 2020-2030 Asia & Pacific Herceptin Market Size And Cagr
Figure 2020-2030 Europe Herceptin Market Size And Cagr
Figure 2020-2030 Mea Herceptin Market Size And Cagr
Figure 2020-2025 Global Herceptin Market Size And Growth Rate
Figure 2025-2030 Global Herceptin Market Size And Growth Rate
Table Research Scope Of Herceptin Report
Table Data Sources Of Herceptin Report
Table Major Assumptions Of Herceptin Report
Table Herceptin Classification
Table Herceptin Applications
Table Drivers Of Herceptin Market
Table Restraints Of Herceptin Market
Table Opportunities Of Herceptin Market
Table Threats Of Herceptin Market
Table Raw Materials Suppliers
Table Different Production Methods Of Herceptin
Table Cost Structure Analysis Of Herceptin
Table Key End Users
Table Latest News Of Herceptin Market
Table Merger And Acquisition
Table Planned/Future Project Of Herceptin Market
Table Policy Of Herceptin Market
Table 2020-2030 North America Herceptin Market Size
Table 2020-2030 North America Herceptin Market Size By Application
Table 2020-2025 North America Herceptin Key Players Revenue
Table 2020-2025 North America Herceptin Key Players Market Share
Table 2020-2030 North America Herceptin Market Size By Type
Table 2020-2030 United States Herceptin Market Size
Table 2020-2030 Canada Herceptin Market Size
Table 2020-2030 Mexico Herceptin Market Size
Table 2020-2030 South America Herceptin Market Size
Table 2020-2030 South America Herceptin Market Size By Application
Table 2020-2025 South America Herceptin Key Players Revenue
Table 2020-2025 South America Herceptin Key Players Market Share
Table 2020-2030 South America Herceptin Market Size By Type
Table 2020-2030 Brazil Herceptin Market Size
Table 2020-2030 Argentina Herceptin Market Size
Table 2020-2030 Chile Herceptin Market Size
Table 2020-2030 Peru Herceptin Market Size
Table 2020-2030 Asia & Pacific Herceptin Market Size
Table 2020-2030 Asia & Pacific Herceptin Market Size By Application
Table 2020-2025 Asia & Pacific Herceptin Key Players Revenue
Table 2020-2025 Asia & Pacific Herceptin Key Players Market Share
Table 2020-2030 Asia & Pacific Herceptin Market Size By Type
Table 2020-2030 China Herceptin Market Size
Table 2020-2030 India Herceptin Market Size
Table 2020-2030 Japan Herceptin Market Size
Table 2020-2030 South Korea Herceptin Market Size
Table 2020-2030 Southeast Asia Herceptin Market Size
Table 2020-2030 Australia Herceptin Market Size
Table 2020-2030 Europe Herceptin Market Size
Table 2020-2030 Europe Herceptin Market Size By Application
Table 2020-2025 Europe Herceptin Key Players Revenue
Table 2020-2025 Europe Herceptin Key Players Market Share
Table 2020-2030 Europe Herceptin Market Size By Type
Table 2020-2030 Germany Herceptin Market Size
Table 2020-2030 France Herceptin Market Size
Table 2020-2030 United Kingdom Herceptin Market Size
Table 2020-2030 Italy Herceptin Market Size
Table 2020-2030 Spain Herceptin Market Size
Table 2020-2030 Belgium Herceptin Market Size
Table 2020-2030 Netherlands Herceptin Market Size
Table 2020-2030 Austria Herceptin Market Size
Table 2020-2030 Poland Herceptin Market Size
Table 2020-2030 Russia Herceptin Market Size
Table 2020-2030 Mea Herceptin Market Size
Table 2020-2030 Mea Herceptin Market Size By Application
Table 2020-2025 Mea Herceptin Key Players Revenue
Table 2020-2025 Mea Herceptin Key Players Market Share
Table 2020-2030 Mea Herceptin Market Size By Type
Table 2020-2030 Egypt Herceptin Market Size
Table 2020-2030 Israel Herceptin Market Size
Table 2020-2030 South Africa Herceptin Market Size
Table 2020-2030 Gulf Cooperation Council Countries Herceptin Market Size
Table 2020-2030 Turkey Herceptin Market Size
Table 2020-2025 Global Herceptin Market Size By Region
Table 2020-2025 Global Herceptin Market Size Share By Region
Table 2020-2025 Global Herceptin Market Size By Application
Table 2020-2025 Global Herceptin Market Share By Application
Table 2020-2025 Global Herceptin Key Vendors Revenue
Table 2020-2025 Global Herceptin Key Vendors Market Share
Table 2020-2025 Global Herceptin Market Size By Type
Table 2020-2025 Global Herceptin Market Share By Type
Table 2025-2030 Global Herceptin Market Size By Region
Table 2025-2030 Global Herceptin Market Size Share By Region
Table 2025-2030 Global Herceptin Market Size By Application
Table 2025-2030 Global Herceptin Market Share By Application
Table 2025-2030 Global Herceptin Key Vendors Revenue
Table 2025-2030 Global Herceptin Key Vendors Market Share
Table 2025-2030 Global Herceptin Market Size By Type
Table 2025-2030 Herceptin Global Market Share By Type
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Herceptin Picture
Figure 2020-2030 North America Herceptin Market Size And Cagr
Figure 2020-2030 South America Herceptin Market Size And Cagr
Figure 2020-2030 Asia & Pacific Herceptin Market Size And Cagr
Figure 2020-2030 Europe Herceptin Market Size And Cagr
Figure 2020-2030 Mea Herceptin Market Size And Cagr
Figure 2020-2025 Global Herceptin Market Size And Growth Rate
Figure 2025-2030 Global Herceptin Market Size And Growth Rate
Research Methodology
- Market Estimated Methodology:
Bottom-up & top-down approach, supply & demand approach are the most important method which is used by HDIN Research to estimate the market size.
1）Top-down & Bottom-up Approach
Top-down approach uses a general market size figure and determines the percentage that the objective market represents.
Bottom-up approach size the objective market by collecting the sub-segment information.
2）Supply & Demand Approach
Supply approach is based on assessments of the size of each competitor supplying the objective market.
Demand approach combine end-user data within a market to estimate the objective market size. It is sometimes referred to as bottom-up approach.
- Forecasting Methodology
- Numerous factors impacting the market trend are considered for forecast model:
- New technology and application in the future;
- New project planned/under contraction;
- Global and regional underlying economic growth;
- Threatens of substitute products;
- Industry expert opinion;
- Policy and Society implication.
- Analysis Tools
1）PEST Analysis
PEST Analysis is a simple and widely used tool that helps our client analyze the Political, Economic, Socio-Cultural, and Technological changes in their business environment.
- Benefits of a PEST analysis:
- It helps you to spot business opportunities, and it gives you advanced warning of significant threats.
- It reveals the direction of change within your business environment. This helps you shape what you’re doing, so that you work with change, rather than against it.
- It helps you avoid starting projects that are likely to fail, for reasons beyond your control.
- It can help you break free of unconscious assumptions when you enter a new country, region, or market; because it helps you develop an objective view of this new environment.
2）Porter’s Five Force Model Analysis
The Porter’s Five Force Model is a tool that can be used to analyze the opportunities and overall competitive advantage. The five forces that can assist in determining the competitive intensity and potential attractiveness within a specific area.
- Threat of New Entrants: Profitable industries that yield high returns will attract new firms.
- Threat of Substitutes: A substitute product uses a different technology to try to solve the same economic need.
- Bargaining Power of Customers: the ability of customers to put the firm under pressure, which also affects the customer's sensitivity to price changes.
- Bargaining Power of Suppliers: Suppliers of raw materials, components, labor, and services (such as expertise) to the firm can be a source of power over the firm when there are few substitutes.
- Competitive Rivalry: For most industries the intensity of competitive rivalry is the major determinant of the competitiveness of the industry.
3）Value Chain Analysis
Value chain analysis is a tool to identify activities, within and around the firm and relating these activities to an assessment of competitive strength. Value chain can be analyzed by primary activities and supportive activities. Primary activities include: inbound logistics, operations, outbound logistics, marketing & sales, service. Support activities include: technology development, human resource management, management, finance, legal, planning.
4）SWOT Analysis
SWOT analysis is a tool used to evaluate a company's competitive position by identifying its strengths, weaknesses, opportunities and threats. The strengths and weakness is the inner factor; the opportunities and threats are the external factor. By analyzing the inner and external factors, the analysis can provide the detail information of the position of a player and the characteristics of the industry.
- Strengths describe what the player excels at and separates it from the competition
- Weaknesses stop the player from performing at its optimum level.
- Opportunities refer to favorable external factors that the player can use to give it a competitive advantage.
- Threats refer to factors that have the potential to harm the player.
- Data Sources
| Primary Sources | Secondary Sources |
|---|---|
| Face to face/Phone Interviews with market participants, such as: Manufactures; Distributors; End-users; Experts. Online Survey |
Government/International Organization Data: Annual Report/Presentation/Fact Book Internet Source Information Industry Association Data Free/Purchased Database Market Research Report Book/Journal/News |